BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28594790)

  • 1. Japanese Encephalitis Surveillance and Immunization - Asia and Western Pacific Regions, 2016.
    Heffelfinger JD; Li X; Batmunkh N; Grabovac V; Diorditsa S; Liyanage JB; Pattamadilok S; Bahl S; Vannice KS; Hyde TB; Chu SY; Fox KK; Hills SL; Marfin AA
    MMWR Morb Mortal Wkly Rep; 2017 Jun; 66(22):579-583. PubMed ID: 28594790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese encephalitis surveillance and immunization--Asia and the Western Pacific, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):658-62. PubMed ID: 23965828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.
    Hills SL; Walter EB; Atmar RL; Fischer M;
    MMWR Recomm Rep; 2019 Jul; 68(2):1-33. PubMed ID: 31518342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese encephalitis: surveillance and immunization in Asia and the Western Pacific, 2016.
    Wkly Epidemiol Rec; 2017 Jun; 92(23):323-31. PubMed ID: 28598135
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction patterns of Japanese encephalitis incidence following vaccine introduction into long-term expanded program on immunization in Yunnan Province, China.
    Hu XT; Li QF; Ma C; Zhao ZX; He LF; Tang TT; Yu W; Owiti P
    Infect Dis Poverty; 2019 Dec; 8(1):102. PubMed ID: 31818328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese encephalitis: status of surveillance and immunization in Asia and the Western Pacific, 2012.
    Wkly Epidemiol Rec; 2013 Aug; 88(34):357-64. PubMed ID: 24040676
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal.
    Upreti SR; Lindsey NP; Bohara R; Choudhary GR; Shakya S; Gautam M; Giri JN; Fischer M; Hills SL
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005866. PubMed ID: 28934197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Travel-acquired Japanese encephalitis and vaccination considerations.
    Pavli A; Maltezou HC
    J Infect Dev Ctries; 2015 Sep; 9(9):917-24. PubMed ID: 26409731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese Encephalitis Vaccines: WHO position paper, February 2015--Recommendations.
    WHO
    Vaccine; 2016 Jan; 34(3):302-3. PubMed ID: 26232543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Japanese encephalitis in the Philippines: a systematic review.
    Lopez AL; Aldaba JG; Roque VG; Tandoc AO; Sy AK; Espino FE; DeQuiroz-Castro M; Jee Y; Ducusin MJ; Fox KK
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003630. PubMed ID: 25794009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-based surveillance for Japanese encephalitis in Bangladesh, 2007-2016: Implications for introduction of immunization.
    Paul KK; Sazzad HMS; Rahman M; Sultana S; Hossain MJ; Ledermann JP; Burns P; Friedman MS; Flora MS; Fischer M; Hills S; Luby SP; Gurley ES
    Int J Infect Dis; 2020 Oct; 99():69-74. PubMed ID: 32721530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of Japanese encephalitis in Asia: the time is now.
    Hills S; Martin R; Marfin A; Fischer M
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):901-4. PubMed ID: 24927959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Japanese encephalitis in the Philippines prior to routine immunization.
    Lopez AL; Raguindin PF; Aldaba JG; Avelino F; Sy AK; Heffelfinger JD; Silva MWT
    Int J Infect Dis; 2021 Jan; 102():344-351. PubMed ID: 33127505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
    Ginsburg AS; Meghani A; Halstead SB; Yaich M
    Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland.
    Hatz C; Werlein J; Mutsch M; Hufnagel M; Behrens RH
    J Travel Med; 2009; 16(3):200-3. PubMed ID: 19538582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Japanese encephalitis in South Korea, 2007-2010.
    Lee DW; Choe YJ; Kim JH; Song KM; Cho H; Bae GR; Lee JK
    Int J Infect Dis; 2012 Jun; 16(6):e448-52. PubMed ID: 22497964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.